Skip to main content
SpringerLink
Log in

How Do We Audit Rectal Cancer Treatment: The EURECCA Perspective

  • Chapter
  • First Online:
Multidisciplinary Management of Rectal Cancer

  • 966 Accesses

Abstract

Randomised controlled trials (RCTs) are considered as the gold standard for determining treatment efficacy. Moreover, the effectiveness of quality control in surgery, radiotherapy, and pathology has been showed in the Dutch TME trial. McArdle and Hole stated in the early 1990s that “some surgeons perform less then optimal surgery; some are less competent technically than their colleagues; and some fail to supervise surgeons in training adequately... If by more meticulous attention to detail the results of surgery could be improved, and our results suggest that this would not be difficult, the impact on survival might be greater than that of any of the adjuvant therapies currently under study” [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. McArdle CS, Hole D (1991) Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ 302(6791):1501–1505

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Guren MG, Korner H, Pfeffer F et al (2015) Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993–2010. Acta Oncol 54:1–9. [Epub ahead of print]

    Article  Google Scholar 

  3. Bulow S, Harling H, Iversen LH, Ladelund S (2010) Improved survival after rectal cancer in Denmark. Colorectal Dis 12(7 Online):e37–e42

    CAS  PubMed  Google Scholar 

  4. Pahlman L, Bohe M, Cedermark B et al (2007) The Swedish rectal cancer registry. Br J Surg 94(10):1285–1292

    Article  CAS  PubMed  Google Scholar 

  5. National Bowel Cancer Audit Report (2014) http://www.hscic.gov.uk/catalogue/PUB16021/nati-clin-audi-supp-prog-bowe-canc-2014-rep1.pdf. Accessed July 2015

  6. Jannasch O, Udelnow A, Romano G et al (2014) International quality assurance project in colorectal cancer-unifying diagnostic and histopathological evaluation. Langenbeck's Arch Surg 399(4):473–479

    Article  CAS  Google Scholar 

  7. Jegou D, Penninckx F, Vandendael T, Bertrand C, Van EE (2015) Completeness and registration bias in PROCARE, a Belgian multidisciplinary project on cancer of the rectum with participation on a voluntary basis. Eur J Cancer 51(9):1099–1108

    Article  CAS  PubMed  Google Scholar 

  8. Codina-Cazador A, Espin E, Biondo S et al (2007) Audited teaching program for the treatment of rectal cancer in Spain: results of the first year. Cir Esp 82(4):209–213

    Article  PubMed  Google Scholar 

  9. Gietelink L, Henneman D, van Leersum NJ et al (2014) The influence of hospital volume on circumferential resection margin involvement: results of the Dutch surgical colorectal audit. Ann Surg 260(3):504–508

    Article  Google Scholar 

  10. Messenger DE, McLeod RS, Kirsch R (2011) What impact has the introduction of a synoptic report for rectal cancer had on reporting outcomes for specialist gastrointestinal and nongastrointestinal pathologists? Arch Pathol Lab Med 135(11):1471–1475

    Article  PubMed  Google Scholar 

  11. Quirke P, West NP, Nagtegaal ID (2014) EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review. Virchows Arch 464(2):129–134

    Article  CAS  PubMed  Google Scholar 

  12. Maniar RL, Hochman DJ, Wirtzfeld DA et al (2014) Documentation of quality of care data for colon cancer surgery: comparison of synoptic and dictated operative reports. Ann Surg Oncol 21(11):3592–3597

    Article  PubMed  Google Scholar 

  13. Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1(8496):1479–1482

    Article  CAS  PubMed  Google Scholar 

  14. van Gijn W, Marijnen CA, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12(6):575–582

    Article  PubMed  Google Scholar 

  15. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93(10):1215–1223

    Article  CAS  PubMed  Google Scholar 

  16. Birkmeyer JD, Siewers AE, Finlayson EV et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128–1137

    Article  PubMed  Google Scholar 

  17. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374–1403

    Article  CAS  PubMed  Google Scholar 

  18. Breugom AJ, Boelens PG, van den Broek CB et al (2014) Quality assurance in the treatment of colorectal cancer: the EURECCA initiative. Ann Oncol 25(8):1485–1492

    Article  CAS  PubMed  Google Scholar 

  19. van de Velde CJ, Aristei C, Boelens PG et al (2013) EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. Eur J Cancer 49(13):2784–2790

    Article  PubMed  Google Scholar 

  20. van den Broek CB, van Gijn W, Bastiaannet E et al (2014) Differences in pre-operative treatment for rectal cancer between Norway, Sweden, Denmark, Belgium and the Netherlands. Eur J Surg Oncol 40(12):1789–1796

    Article  PubMed  Google Scholar 

  21. International watch and wait database. http://www.iwwd.org/. Accessed July 2015

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands

    Anne J. Breugom & Cornelis J. H. van de Velde

Authors
  1. Anne J. Breugom
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cornelis J. H. van de Velde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cornelis J. H. van de Velde .

Editor information

Editors and Affiliations

  1. Dept. of Radiation Oncology, Università Cattolica S Cuore, Rome, Italy

    Vincenzo Valentini

  2. Head, Div. Clinical Oncology Research, University Clinic Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany

    Hans-Joachim Schmoll

  3. Department of Surgery, Leiden Univ Med Ctr, Leiden, The Netherlands

    Cornelis J. H. van de Velde

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag Berlin Heidelberg

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Breugom, A.J., van de Velde, C.J.H. (2018). How Do We Audit Rectal Cancer Treatment: The EURECCA Perspective. In: Valentini, V., Schmoll, HJ., van de Velde, C. (eds) Multidisciplinary Management of Rectal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-43217-5_72

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43217-5_72

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43215-1

  • Online ISBN: 978-3-319-43217-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation